The use of artificial intelligence (AI) in digital pathology has proposed faster workflows, more accurate diagnoses, and the opportunity to discover new insights that we can harness to improve patient care. Thousands of academic papers demonstrate new AI algorithms each year, yet only a handful of these ever make it into the world of clinical care.
PathAI, the global leader in AI-powered pathology, today announced the integration of AIM-HI UC1, an advanced AI model for Ulcerative Colitis (UC) histology endpoint assessment, on to AISight™ Clinical Trials, PathAI’s GCP and GCLP-compliant platform. AIM-HI UC1 was developed by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium’s Mucosal Healing in Ulcerative Colitis Project [...]
By Dr. Keith J. Kaplan Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI’s datasets from 7 million slides, perhaps most of which were from Memorial Sloan Kettering Cancer Center. Critics [...]
By Rupesh Mishra & Coleman Stavish Rupesh Mishra, Healthcare Solutions Architect, Amazon Web Services, and Coleman Stavish, CTO, Proscia At Proscia, we’re committed to making digital pathology effortless, scalable, and enterprise-ready for our customers. That’s why Concentriq—our flagship enterprise pathology platform—is delivered as a cloud-native SaaS solution hosted on Amazon Web Services [...]
IEO ranks among the world's top cancer research institutes with over 18,000 patients served annually Partnership will leverage AI to identify and validate new biomarkers and therapeutic targets Collaboration includes comprehensive research initiatives and potential integration of AI tools into clinical workflows Owkin and Istituto Europeo di Oncologia (IEO) have announced a strategic partnership to [...]
elea AI, a developer of modern, AI-assisted software solutions for clinical practice, reports a highly successful participation at the 37th European Congress of Pathology (ECP) in Vienna. The company's advanced Pathology Information System (PIS) was a focal point of discussion, drawing strong interest from industry leaders and pathology professionals. The 37th ECP served as a key [...]
Mindpeak, a global leader in AI powered pathology, today announced the appointment of Christiaan Neeleman to its Board of Directors. Neeleman brings more than two decades of international leadership in life sciences, diagnostics and health technology, adding strategic depth as Mindpeak accelerates its global growth and deepens its partnerships across pharma, biotech, and diagnostics. Neeleman’s significant [...]
AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform Proscia®, a pathology AI company, today announced the next step in its collaboration with Amazon Web Services (AWS) to address two of digital pathology’s most pressing challenges: managing surging data volumes and standardizing siloed data. It has integrated its Concentriq® platform for pathology [...]
By Jenna Karpel Overview: The Clinical Trials Module in HALO AP Platforms The Clinical Trials module in HALO AP®, a CE-IVDR marked and AI-powered platform for primary diagnosis, and HALO AP Dx, an FDA-cleared platform for primary diagnosis, provide pathologists and researchers access to comprehensive digital pathology tools for building objective, unbiased datasets that [...]
Dr. David Klimstra’s Presentation to PNPL’s Digital Pathology & AI Focus Group On June 27, 2025, Dr. David S. Klimstra, Professor of Pathology at Yale University School of Medicine and Co-Founder of Paige AI, gave a compelling presentation to PNPL’s Digital Pathology and AI Focus Group. Drawing on his leadership in both academic pathology and AI innovation, Dr. [...]
